RESEND: open position at SmithKline Beecham for a C. elegans

George_P_Livi at sbphrd.com George_P_Livi at sbphrd.com
Wed Feb 3 10:38:16 EST 1999


                    SMITHKLINE BEECHAM PHARMACEUTICALS

            Ph.D. Scientist -- Comparative Genetics,C. elegans

SmithKline  Beecham  is  a  leader  in  functional  genomics  as applied to
pharmaceutical  research  and  development.   Our Department of Comparative
Genetics  conducts  gene-based  biology in model organisms (primarily yeast
and  mouse) to identify and validate drug targets, to develop drug screens,
and  to  generate  animal  models  for  human  disease.   We  are currently
expanding to create an inhouse Caenorhabditis elegans genetics group.

The successful candidate will be the principal investigator to lead our new
initiative  in  C. elegans genetics, and will exploit C. elegans as a model
organism  to  identify  and  characterize  the functions of novel genes and
their  human  counterparts.  C.  elegans  genetics  will  also  be  used to
investigate the mechanisms of action of pharmaceutical agents.

Requires:  Ph.D. in Genetics or related discipline; 2-5 years post-doctoral
experience;  a  strong  background  in classical and recombinant C. elegans
genetics;  and  a  proven  record of scientific achievement as evidenced by
publications in leading scientific journals.  SmithKline Beecham scientists
are encouraged to publish their research findings.

Located  in  our  state-of-the-art  R&D  facility in suburban Philadelphia,
SmithKline  Beecham offers a competitive benefits and compensation package,
as  well as a challenging work environment. Please submit your confidential
resume, the names of three references, and salary requirements to:

George P. Livi, Ph.D.
Associate Director and Head
Department of Comparative Genetics, UE0548A
SmithKline Beecham Pharmaceuticals
P.O. Box 1539
King of Prussia, PA 19406 USA
(610) 270-7717
(610) 270-7962 (FAX)
e-mail: George_P_Livi at sbphrd.com

We are an Equal Opportunity Employer, M/F/D/V.





More information about the Celegans mailing list